 | SOT | Name: | morpholine-4-sulfonic acid | Formula: | C4 H9 N O4 S | SMILES: | O=S(=O)(O)N1CCOCC1 | InChi: | InChI=1S/C4H9NO4S/c6-10(7,8)5-1-3-9-4-2-5/h1-4H2,(H,6,7,8) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | morpholine-4-sulfonic acid |
|
 | SOW | Name: | [(2-amino-2-oxoethyl)amino]acetic acid | Formula: | C4 H8 N2 O3 | SMILES: | NC(=O)CNCC(=O)O | InChi: | InChI=1S/C4H8N2O3/c5-3(7)1-6-2-4(8)9/h6H,1-2H2,(H2,5,7)(H,8,9) | Definition date: | 2022-07-07 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | [(2-amino-2-oxoethyl)amino]acetic acid |
|
 | SPD | Name: | SPERMIDINE | Formula: | C7 H19 N3 | SMILES: | NCCCNCCCCN | InChi: | InChI=1S/C7H19N3/c8-4-1-2-6-10-7-3-5-9/h10H,1-9H2 | Synonyms: | N-(2-AMINO-PROPYL)-1,4-DIAMINOBUTANE | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-(3-aminopropyl)butane-1,4-diamine |
|
 | SPM | Name: | SPERMINE | Formula: | C10 H26 N4 | SMILES: | NCCCNCCCCNCCCN | InChi: | InChI=1S/C10H26N4/c11-5-3-9-13-7-1-2-8-14-10-4-6-12/h13-14H,1-12H2 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N,N'-bis(3-aminopropyl)butane-1,4-diamine |
|
 | SQ3 | Name: | (1R,2S,5S)-3-[(2,4-dichlorophenoxy)acetyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | Formula: | C23 H29 Cl2 N3 O5 | SMILES: | CC1(C)C2C(C(=O)NC(CC3CCNC3=O)CO)N(CC21)C(=O)COc1ccc(Cl)cc1Cl | InChi: | InChI=1S/C23H29Cl2N3O5/c1-23(2)15-9-28(18(30)11-33-17-4-3-13(24)8-16(17)25)20(19(15)23)22(32)27-14(10-29)7-12-5-6-26-21(12)31/h3-4,8,12,14-15,19-20,29H,5-7,9-11H2,1-2H3,(H,26,31)(H,27,32)/t12-,14-,15-,19-,20-/m0/s1 | Definition date: | 2023-08-28 | Last modified: | 2024-09-27 | Release date: | 2024-08-28 | Identifier: | (1R,2S,5S)-3-[(2,4-dichlorophenoxy)acetyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
|
 | SQ6 | Name: | 2,2'-azanediyldiacetic acid | Formula: | C4 H7 N O4 | SMILES: | O=C(O)CNCC(=O)O | InChi: | InChI=1S/C4H7NO4/c6-3(7)1-5-2-4(8)9/h5H,1-2H2,(H,6,7)(H,8,9) | Definition date: | 2022-07-07 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | 2,2'-azanediyldiacetic acid |
|
 | SQI | Name: | hexadecan-1-amine | Formula: | C16 H35 N | SMILES: | CCCCCCCCCCCCCCCCN | InChi: | InChI=1S/C16H35N/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h2-17H2,1H3 | Definition date: | 2022-07-07 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | hexadecan-1-amine |
|
 | SQW | Name: | propan-2-yl 4-indol-1-yl-4-oxidanylidene-butanoate | Formula: | C15 H17 N O3 | SMILES: | CC(C)OC(=O)CCC(=O)n1ccc2ccccc12 | InChi: | InChI=1S/C15H17NO3/c1-11(2)19-15(18)8-7-14(17)16-10-9-12-5-3-4-6-13(12)16/h3-6,9-11H,7-8H2,1-2H3 | Definition date: | 2020-11-30 | Last modified: | 2024-09-27 | Release date: | 2021-08-04 | Identifier: | propan-2-yl 4-indol-1-yl-4-oxidanylidene-butanoate |
|
 | SR2 | Name: | (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide | Formula: | C20 H20 Br N5 O | SMILES: | Brc1cccc(c1)Nc3ncnc2c3cc(cc2)NC(=O)/C=C/CN(C)C | InChi: | InChI=1S/C20H20BrN5O/c1-26(2)10-4-7-19(27)24-16-8-9-18-17(12-16)20(23-13-22-18)25-15-6-3-5-14(21)11-15/h3-9,11-13H,10H2,1-2H3,(H,24,27)(H,22,23,25)/b7-4+ | Definition date: | 2007-08-06 | Last modified: | 2024-09-27 | Identifier: | (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide |
|
 | SR3 | Name: | (2S,3R)-4-(2-amino-2-oxoethoxy)-3-(dihydroxy-lambda~4~-sulfanyl)-3-methyl-4-oxo-2-{[(1E)-3-oxoprop-1-en-1-yl]amino}butanoic acid | Formula: | C10 H16 N2 O8 S | SMILES: | O=C(O)C(NC=CC=O)C(C(=O)OCC(=O)N)(C)S(O)O | InChi: | InChI=1S/C10H16N2O8S/c1-10(21(18)19,9(17)20-5-6(11)14)7(8(15)16)12-3-2-4-13/h2-4,7,12,18-19,21H,5H2,1H3,(H2,11,14)(H,15,16)/b3-2+/t7-,10+/m0/s1 | Definition date: | 2011-05-12 | Last modified: | 2024-09-27 | Identifier: | (2S,3R)-4-(2-amino-2-oxoethoxy)-3-(dihydroxy-lambda~4~-sulfanyl)-3-methyl-4-oxo-2-{[(1E)-3-oxoprop-1-en-1-yl]amino}butanoic acid (non-preferred name) |
|
 | SRB | Name: | L-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID | Formula: | C14 H17 B N O4 | SMILES: | O=C(NC([B-](O)(O)O)Cc2cccc1ccccc12)C | InChi: | InChI=1S/C14H17BNO4/c1-10(17)16-14(15(18,19)20)9-12-7-4-6-11-5-2-3-8-13(11)12/h2-8,14,18-20H,9H2,1H3,(H,16,17)/q-1/t14-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | [(1R)-1-(acetylamino)-2-naphthalen-1-ylethyl](trihydroxy)borate(1-) |
|
 | SRD | Name: | D-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID | Formula: | C14 H17 B N O4 | SMILES: | O=C(NC([B-](O)(O)O)Cc2cccc1ccccc12)C | InChi: | InChI=1S/C14H17BNO4/c1-10(17)16-14(15(18,19)20)9-12-7-4-6-11-5-2-3-8-13(11)12/h2-8,14,18-20H,9H2,1H3,(H,16,17)/q-1/t14-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | [(1S)-1-(acetylamino)-2-naphthalen-1-ylethyl](trihydroxy)borate(1-) |
|
 | SRG | Name: | (2S)-2-[[(2S)-1-[[(5S,8S,9E)-2,7-dioxo-5-propan-2-yl-1,6-diazacyclododeca-3,9-dien-8-yl]amino]-3-methyl-1-oxo-butan-2-yl]carbamoylamino]-3-methyl-butanoic acid | Formula: | C24 H39 N5 O6 | SMILES: | O=C(O)C(NC(=O)NC(C(=O)NC1C(=O)NC(C=CC(=O)NCCC=C1)C(C)C)C(C)C)C(C)C | InChi: | InChI=1S/C24H39N5O6/c1-13(2)16-10-11-18(30)25-12-8-7-9-17(21(31)26-16)27-22(32)19(14(3)4)28-24(35)29-20(15(5)6)23(33)34/h7,9-11,13-17,19-20H,8,12H2,1-6H3,(H,25,30)(H,26,31)(H,27,32)(H,33,34)(H2,28,29,35)/b9-7+,11-10?/t16-,17+,19+,20+/m1/s1 | Synonyms: | Syringolin A | Definition date: | 2007-11-20 | Last modified: | 2024-09-27 | Identifier: | N-{[(1S)-2-methyl-1-{[(3E,5S,8S,9E)-5-(1-methylethyl)-2,7-dioxo-1,6-diazacyclododeca-3,9-dien-8-yl]carbamoyl}propyl]carbamoyl}-L-valine |
|
 | SRH | Name: | ethyl 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoate | Formula: | C14 H17 N O3 | SMILES: | CCOC(=O)CCC(=O)N1CCc2ccccc12 | InChi: | InChI=1S/C14H17NO3/c1-2-18-14(17)8-7-13(16)15-10-9-11-5-3-4-6-12(11)15/h3-6H,2,7-10H2,1H3 | Definition date: | 2020-11-30 | Last modified: | 2024-09-27 | Release date: | 2021-08-04 | Identifier: | ethyl 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoate |
|
 | SRM | Name: | SIROHEME | Formula: | C42 H44 Fe N4 O16 | SMILES: | O=C(O)CCC=6C7=Cc1c(c(c2n1[Fe]84N5C(=CC3=C(CCC(=O)O)C(C(=C2)N34)(C)CC(=O)O)C(C(=C5C=C(C=6CC(=O)O)N78)CCC(=O)O)(C)CC(=O)O)CC(=O)O)CCC(=O)O | InChi: | InChI=1S/C42H46N4O16.Fe/c1-41(17-39(59)60)23(5-9-35(51)52)29-14-27-21(11-37(55)56)19(3-7-33(47)48)25(43-27)13-26-20(4-8-34(49)50)22(12-38(57)58)28(44-26)15-31-42(2,18-40(61)62)24(6-10-36(53)54)30(46-31)16-32(41)45-29 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | {3,3',3'',3'''-[(8S,13S)-3,8,13,17-tetrakis(carboxymethyl)-8,13-dimethyl-8,13,22,24-tetrahydroporphyrin-2,7,12,18-tetrayl-kappa~4~N~21~,N~22~,N~23~,N~24~]tetrapropanoato(4-)}iron |
|
 | SRO | Name: | SEROTONIN | Formula: | C10 H12 N2 O | SMILES: | Oc1cc2c(cc1)ncc2CCN | InChi: | InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2 | Synonyms: | 3-(2-AMINOETHYL)-1H-INDOL-5-OL | Definition date: | 2007-07-11 | Last modified: | 2024-09-27 | Identifier: | 3-(2-aminoethyl)-1H-indol-5-ol |
|
 | SRQ | Name: | 2,2-bis(fluoranyl)ethyl 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoate | Formula: | C14 H15 F2 N O3 | SMILES: | FC(F)COC(=O)CCC(=O)N1CCc2ccccc12 | InChi: | InChI=1S/C14H15F2NO3/c15-12(16)9-20-14(19)6-5-13(18)17-8-7-10-3-1-2-4-11(10)17/h1-4,12H,5-9H2 | Definition date: | 2020-11-30 | Last modified: | 2024-09-27 | Release date: | 2021-08-04 | Identifier: | 2,2-bis(fluoranyl)ethyl 4-(2,3-dihydroindol-1-yl)-4-oxidanylidene-butanoate |
|
 | SRU | Name: | 1-[(5S)-5-(3,4-dimethoxyphenyl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one | Formula: | C19 H20 N2 O3 | SMILES: | O=C(C)N1N=C(CC1c1ccc(OC)c(OC)c1)c1ccccc1 | InChi: | InChI=1S/C19H20N2O3/c1-13(22)21-17(12-16(20-21)14-7-5-4-6-8-14)15-9-10-18(23-2)19(11-15)24-3/h4-11,17H,12H2,1-3H3/t17-/m0/s1 | Definition date: | 2022-07-08 | Last modified: | 2024-09-27 | Release date: | 2023-05-17 | Identifier: | 1-[(5S)-5-(3,4-dimethoxyphenyl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one |
|
 | SRZ | Name: | PROPOXY-L-SERINE | Formula: | C6 H13 N O4 | SMILES: | O=C(O)C(N)COCCCO | InChi: | InChI=1S/C6H13NO4/c7-5(6(9)10)4-11-3-1-2-8/h5,8H,1-4,7H2,(H,9,10)/t5-/m0/s1 | Definition date: | 2013-11-05 | Last modified: | 2024-09-27 | Release date: | 2013-12-04 | Identifier: | O-(3-hydroxypropyl)-L-serine |
|
 | SSH | Name: | 3-DEOXY-D-ARABINO-HEXONIC ACID | Formula: | C6 H12 O6 | SMILES: | O=C(O)C(O)CC(O)C(O)CO | InChi: | InChI=1S/C6H12O6/c7-2-5(10)3(8)1-4(9)6(11)12/h3-5,7-10H,1-2H2,(H,11,12)/t3-,4-,5+/m0/s1 | Synonyms: | D-2-KETO-3-DEOXYGLUCONATE | Definition date: | 2004-07-17 | Last modified: | 2024-09-27 | Identifier: | 3-deoxy-D-arabino-hexonic acid |
|
 | SSN | Name: | 4-oxobutanoic acid | Formula: | C4 H6 O3 | SMILES: | O=CCCC(=O)O | InChi: | InChI=1S/C4H6O3/c5-3-1-2-4(6)7/h3H,1-2H2,(H,6,7) | Synonyms: | Succinic semialdehyde | Definition date: | 2011-01-31 | Last modified: | 2024-09-27 | Identifier: | 4-oxobutanoic acid |
|
 | STA | Name: | STATINE | Formula: | C8 H17 N O3 | SMILES: | O=C(O)CC(O)C(N)CC(C)C | InChi: | InChI=1S/C8H17NO3/c1-5(2)3-6(9)7(10)4-8(11)12/h5-7,10H,3-4,9H2,1-2H3,(H,11,12)/t6-,7-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (3S,4S)-4-amino-3-hydroxy-6-methylheptanoic acid |
|
 | STE | Name: | STEARIC ACID | Formula: | C18 H36 O2 | SMILES: | O=C(O)CCCCCCCCCCCCCCCCC | InChi: | InChI=1S/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | octadecanoic acid |
|
 | STH | Name: | 2-AMINO-4H-1,3-BENZOXATHIIN-4-OL | Formula: | C8 H9 N O2 S | SMILES: | O2c1ccccc1C(O)SC2N | InChi: | InChI=1S/C8H9NO2S/c9-8-11-6-4-2-1-3-5(6)7(10)12-8/h1-4,7-8,10H,9H2/t7-,8+/m1/s1 | Definition date: | 2004-11-03 | Last modified: | 2024-09-27 | Identifier: | (2S,4R)-2-amino-4H-1,3-benzoxathiin-4-ol |
|
 | ODN | Name: | (1beta,6beta,7beta,8alpha,9beta,10alpha,13alpha,14R,16beta)-1,6,7,14-tetrahydroxy-7,20-epoxykauran-15-one | Formula: | C20 H30 O6 | SMILES: | O=C2C(C)C4CCC3C51C(C(O)C(O)(OC1)C23C4O)C(CCC5O)(C)C | InChi: | InChI=1S/C20H30O6/c1-9-10-4-5-11-18-8-26-20(25,19(11,14(9)22)15(10)23)16(24)13(18)17(2,3)7-6-12(18)21/h9-13,15-16,21,23-25H,4-8H2,1-3H3/t9-,10+,11+,12+,13-,15-,16+,18-,19+,20-/m1/s1 | Definition date: | 2014-04-25 | Last modified: | 2024-09-27 | Release date: | 2014-10-15 | Identifier: | (1beta,6beta,7beta,8alpha,9beta,10alpha,13alpha,14R,16beta)-1,6,7,14-tetrahydroxy-7,20-epoxykauran-15-one |
|